The Surgical Management of Head and Neck Sarcoma: The Newcastle Experience
Abstract Introduction Sarcomas occurring in the head and neck are rare and difficult to manage surgically. Factors which influence prognosis include; type and grade of tumour, resection margins, anatomical site and patient specific factors. We review our experience of managing these tumours surgical...
Saved in:
Published in | Journal of plastic, reconstructive & aesthetic surgery Vol. 70; no. 1; pp. 78 - 84 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.01.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract Introduction Sarcomas occurring in the head and neck are rare and difficult to manage surgically. Factors which influence prognosis include; type and grade of tumour, resection margins, anatomical site and patient specific factors. We review our experience of managing these tumours surgically as plastic surgeons within a bone and soft tissue tumour multi disciplinary team. Methods Data on all patients with sarcoma of the head or neck managed surgically from 2004-2014 was reviewed. Demographics, surgical details and outcomes were analysed. Results Forty-nine patients underwent surgery for sarcoma of the head or neck. The mean age at presentation was 53.1 years (range 0.5-92). Histological diagnosis was varied. Leiomyosarcoma (n=6), angiosarcoma (n=9), synovial sarcoma (n=4), sarcoma of no specific type (n=5) and rhabdomyosarcoma (n=5) were the most frequently seen tumours. All were treated by wide excision. Excision margins were histologically complete in the vast majority (n=43). Reconstruction was undertaken as follows: direct closure (n=12), local flap +- skin graft (n=12), free tissue transfer (n=21), pedicled flap +- skin graft (n=3), skin graft (n=1). Twelve patients received adjuvant chemotherapy and fifteen patients received adjuvant radiotherapy. Eleven patients developed local recurrence and ten patients developed metastasis. Twelve patients died of their disease; mean survival 17 months (range 8-28). The mean duration of follow up was 78 months (range 18-137 months). Estimated 5-year disease specific survival for this cohort was 72% and overall estimated survival was 61% (Kaplan-Meier equation). Conclusion Head and neck sarcomas are rare and challenging to manage. Successful outcomes can be achieved by early, aggressive resection and appropriate reconstruction within the specialist MDT setting. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1748-6815 1878-0539 |
DOI: | 10.1016/j.bjps.2016.09.026 |